list of glp 1 agonists Receptor Indications for GLP-1/GIP RA Summary

52 These results, in part, supported the development of orforglipron as an orally delivered GLP-1RA in clinical testing

The brain receptors drive the appetite suppression that produces weight loss

4,7 In this regard, this addition ensures a more comprehensive discussion aligned with current expert consensus on risk mitigation strategies

Approval for Diabetes and Weight Management Over the past decade, three GLP-1/GIP receptor agonists liraglutide, semaglutide, and tirzepatide initially approved by the FDA for adults with type 2 diabetes, have also gained FDA approval for chronic weight management in people without diabetes, provided they meet specific criteria: a BMI of 30, or 27 with at least one weight-related condition such as hypertension, dyslipidemia, or type 2 diabetes

Combination Approaches Future treatments might combine incretin agonists with other weight loss mechanisms like metabolism boosters, appetite suppressants working through non-incretin pathways, or fat absorption inhibitors

The linkage between PEG and the drug molecule can be either stable or degradable, the latter being commonly used for prodrugs